Barbolina and colleagues were able to demonstrate that downregulation of CX3CR1 leads to reduced peritoneal metastasis, and increased receptor expression in human ovarian cancer was associated with a worsened prognosis [10]. This evidence concerns the gene CX3CR1 and ovarian cancer.